Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults
NCT00439959
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C, Chronic
Hepatitis C
Interventions
DRUG:
GSK625433/placebo
Sponsor
GlaxoSmithKline